Lista de obras - Elvira Favoino - Dominio Público Uruguay

Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma

artículo científico publicado en 2016

Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin

artículo científico publicado en 2015

Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma

artículo científico publicado en 2016

Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis

artículo científico publicado en 2013

Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide

artículo científico publicado en 2003

CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases

artículo científico publicado en 2005

CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases

artículo científico publicado en 2016

CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading

scientific article published in 2019

CD20: a target antigen for immunotherapy of autoimmune diseases

artículo científico publicado en 2005

Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis

artículo científico publicado en 2013

Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis

artículo científico publicado en 2015

Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice

article

Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4

artículo científico publicado en 2011

Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor

artículo científico publicado en 2005

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma.

artículo científico publicado en 2015

Harnessing host innate immunity may combat acquired resistance to BRAFi

artículo científico publicado en 2014

Human CD4 mimicry by anti-idiotypic monoclonal antibody 16D7 is based on a conformational epitope

artículo científico publicado en 2004

Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: implication for peptide-based active immunotherapy

artículo científico publicado en 2007

Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence

article

Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders

artículo científico publicado en 2018

Raynaud's phenomenon: from molecular pathogenesis to therapy

artículo científico publicado en 2014

Rheumatic disorders as paraneoplastic syndromes

artículo científico publicado en 2008

Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count

artículo científico publicado en 2008

Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease

artículo científico publicado en 2016

The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells

artículo científico publicado en 2011

Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes

artículo científico publicado en 2009

Lista de obras de Elvira Favoino

Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma

Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin

Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma

Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis

Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide

CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases

CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases

CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading

CD20: a target antigen for immunotherapy of autoimmune diseases

Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis

Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis

Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice

Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4

Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma.

Harnessing host innate immunity may combat acquired resistance to BRAFi

Human CD4 mimicry by anti-idiotypic monoclonal antibody 16D7 is based on a conformational epitope

Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: implication for peptide-based active immunotherapy

Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence

Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders

Raynaud's phenomenon: from molecular pathogenesis to therapy

Rheumatic disorders as paraneoplastic syndromes

Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count

Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease

The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells

Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes